BMY Bristol Myers Squibb Co

  1. Stocks
  2. Healthcare
  3. NYSE: BMY

Price (delayed)

$47.84

Market cap

$96.74B

P/E Ratio

12.33

Dividend/share

$2.34

EPS

$3.88

Enterprise value

$125.05B

Bristol Myers Squibb is an American pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, ...

Highlights
The quick ratio has increased by 35% QoQ and by 20% YoY
The stock's price to earnings (P/E) is 24% less than its last 4 quarters average of 16.2
Bristol Myers Squibb's EPS has increased by 31% YoY but it has decreased by 2.3% QoQ
The net income has grown by 27% year-on-year but it has declined by 3.1% since the previous quarter
BMY's debt is up by 6% since the previous quarter
Bristol Myers Squibb's gross profit has decreased by 4.7% YoY
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: https://www.bms.com/
Peers: MRK LLY PFE NVS

Key stats

What are the main financial stats of BMY
Market
Shares outstanding
2.02B
Market cap
$96.74B
Enterprise value
$125.05B
Valuations
Price to earnings (P/E)
12.33
Price to book (P/B)
3.31
Price to sales (P/S)
2.16
EV/EBIT
14.84
EV/EBITDA
6.88
EV/Sales
2.78
Earnings
Revenue
$45.01B
EBIT
$8.43B
EBITDA
$18.19B
Free cash flow
$12.65B
Per share
EPS
$3.88
Free cash flow per share
$6.22
Book value per share
$14.46
Revenue per share
$22.12
TBVPS
$23.06
Balance sheet
Total assets
$95.16B
Total liabilities
$65.67B
Debt
$39.77B
Equity
$29.43B
Working capital
$9.51B
Liquidity
Debt to equity
1.35
Current ratio
1.43
Quick ratio
1.04
Net debt/EBITDA
1.56
Margins
EBITDA margin
40.4%
Gross margin
76.2%
Net margin
17.8%
Operating margin
18.8%
Efficiency
Return on assets
8.6%
Return on equity
26.3%
Return on invested capital
16.8%
Return on capital employed
11.6%
Return on sales
18.7%
Dividend
Dividend yield
4.89%
DPS
$2.34
Payout ratio
60.3%

BMY stock price

How has the Bristol Myers Squibb stock price performed over time
Intraday
-0.87%
1 week
-4.87%
1 month
-8.6%
1 year
-32.24%
YTD
-6.76%
QTD
-11.78%

Financial performance

How have Bristol Myers Squibb's revenue and profit performed over time
Revenue
$45.01B
Gross profit
$34.31B
Operating income
$8.44B
Net income
$8.03B
Gross margin
76.2%
Net margin
17.8%
BMY's net margin is up by 30% year-on-year but it is down by 3.3% since the previous quarter
The net income has grown by 27% year-on-year but it has declined by 3.1% since the previous quarter
The operating margin has increased by 13% year-on-year but it has declined by 2.1% since the previous quarter
The operating income rose by 9% year-on-year but it has declined by 2.1% since the previous quarter

Growth

What is Bristol Myers Squibb's growth rate over time

Valuation

What is Bristol Myers Squibb stock price valuation
BMY P/E details
P/E
12.33
P/B
3.31
P/S
2.16
EV/EBIT
14.84
EV/EBITDA
6.88
EV/Sales
2.78
Bristol Myers Squibb's EPS has increased by 31% YoY but it has decreased by 2.3% QoQ
The stock's price to earnings (P/E) is 24% less than its last 4 quarters average of 16.2
BMY's P/B is 19% below its last 4 quarters average of 4.1 and 15% below its 5-year quarterly average of 3.9
Bristol Myers Squibb's equity has decreased by 5% YoY
The price to sales (P/S) is 35% less than the 5-year quarterly average of 3.3 and 23% less than the last 4 quarters average of 2.8
The company's revenue fell by 2.5% YoY

Efficiency

How efficient is Bristol Myers Squibb business performance
Bristol Myers Squibb's ROA has increased by 34% YoY but it has decreased by 2.3% from the previous quarter
The ROE has grown by 33% YoY
Bristol Myers Squibb's return on sales has increased by 12% YoY but it has decreased by 2.6% QoQ
BMY's return on invested capital is up by 11% year-on-year but it is down by 4.5% since the previous quarter

Dividends

What is BMY's dividend history
Dividend details
DPS
$2.34
Dividend yield
4.89%
Payout ratio
60.3%
Recent dividends

Financial health

How did Bristol Myers Squibb financials performed over time
BMY's total assets is 45% greater than its total liabilities
The quick ratio has increased by 35% QoQ and by 20% YoY
Bristol Myers Squibb's current ratio has increased by 21% from the previous quarter and by 14% YoY
BMY's debt is 35% greater than its equity
The company's debt to equity rose by 6% YoY and by 3.8% QoQ
BMY's debt is up by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.